Table VII.
Final Model with for White Participants in SARP (n=649)
| Variable | OR | 95%CI | p>|z| |
|---|---|---|---|
| Age | 1.02 | 1.00–1.04 | 0.046 |
| Center | 0.88 | 0.81–0.95 | 0.001 |
| BMI | 1.00 | 0.98–1.03 | 0.790 |
| Age Onset | 1.00 | 0.99–1.02 | 0.866 |
| 1 Family History | 0.67 | 0.42–1.09 | 0.108 |
| 2+ Family History | 0.57 | 0.32–1.00 | 0.051 |
| Pets | 0.65 | 0.42–1.00 | 0.051 |
| GERD | 1.92 | 1.18–3.13 | 0.009 |
| Diabetes | 2.27 | 0.82–6.29 | 0.114 |
| Baseline FEV1% pred | 0.94 | 0.93–0.95 | <.0001 |
*
Age=Age when enrolled into SARP, Center= clinical center site, Age Onset=Age when first diagnosed with asthma, 1 Family History= Have 1 family member with asthma, 2+ Family History= Have 2 or more family members with asthma, Pets=own any pets, GERD=gastroesophogeal reflux disease, FEV1=forced expiratory volume in one second
*
Adjusted for current age (age of SARP enrollment) & clinical center